NEWS RELEASE
FOR IMMEDIATE RELEASE
September 9, 2022

Sentec acquires Percussionaire

Therwil, Switzerland — Focused on advancing respiratory care, Sentec has acquired Percussionaire. Percussionaire was founded nearly 40 years ago by the late Dr. Forrest Bird who was a pioneer in respiratory care.

“For us, this acquisition is a unique opportunity to build on the legacy of Dr. Bird and continue to invest in products that make a positive impact to patient care,” said Chairman of Sentec, AG, Dominik Ellenrieder, “In this new era, with COVID reminding us of the importance of respiratory monitoring and therapies, we believe the Percussionaire products have an important part to play to improve patient care by enabling the least invasive interventions.”

With this acquisition, Sentec will diversify its product lines focused on respiratory monitoring to now include the Percussionaire range of products built on TRUE-IPV® technology, increasing its ability to service and support respiratory care customers.  Both Sentec and Percussionaire product lines play vital roles in the management of critical care patients; Bringing these products together provides the unique ability to simultaneously monitor and treat patients with varying levels of compromised respiratory function.

About Percussionaire (www.percussionaire.com)

Percussionaire is a specialty ventilation company that develops, manufactures, and markets products that are used in respiratory care.  The company was formed nearly 40 years ago in Sandpoint, ID, still the home of its manufacturing and research and development facility, where Percussionaire continues to build on the legacy of its founder, Dr. Forrest Bird. His breakthrough of Flow Ventilation and True-IPV® technology is at the heart of Percussionaire, the only company offering these solutions across all patient types and clinical settings.

About Sentec (www.sentec.com)

Sentec is a market leader of non-invasive monitoring solutions who develops, manufactures, and markets patient-centric, cost-effective technologies and products that provide clinicians with greater insight to quickly to identify trends, rapidly and more accurately assess patient status, and make well-informed, timely care decisions that can improve patient care. Sentec is driven by the belief that noninvasive monitoring should enable the delivery of less invasive care.

Sentec Headquarters is in Basel Switzerland.

Inquiries:  Brittany Wishart, Director of Marketing, Sentec 443.510.7425